MFN Partners’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

MFN Partners’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,209	Closed	-$437K	–	12
2024 Q3	$437K	Hold	24,209	–	–	0.01%	12
2024 Q2	$386K	Hold	24,209	–	–	0.01%	10
2024 Q1	$542K	Hold	24,209	–	–	0.02%	10
2023 Q4	$568K	Hold	24,209	–	–	0.02%	12
2023 Q3	$576K	Hold	24,209	–	–	0.02%	13
2023 Q2	$696K	Hold	24,209	–	–	0.02%	14
2023 Q1	$1.47M	Hold	24,209	–	–	0.07%	15
2022 Q4	$2.22M	Hold	24,209	–	–	0.1%	16
2022 Q3	$2.92M	Hold	24,209	–	–	0.13%	17
2022 Q2	$1.86M	Hold	24,209	–	–	0.08%	16
2022 Q1	$3.76M	Hold	24,209	–	–	0.13%	20
2021 Q4	$5.83M	Hold	24,209	–	–	0.23%	14
2021 Q3	$10.4M	Hold	24,209	–	–	0.48%	14
2021 Q2	$13.2M	Buy	24,209 +6,868	+40%	+$430K	0.71%	13
2021 Q1	$6.77M	Hold	17,341	–	–	0.5%	15
2020 Q4	$7.43M	Hold	17,341	–	–	0.66%	14
2020 Q3	$14.8M	Hold	17,341	–	–	1.21%	14
2020 Q2	$14.3M	Hold	17,341	–	–	2%	9
2020 Q1	$6.43M	Buy	17,341 +6,713	+63%	+$479K	0.85%	13
2019 Q4	$4.05M	Hold	10,628	–	–	0.83%	10
2019 Q3	$18M	Hold	10,628	–	–	2.7%	10
2019 Q2	$17M	Buy	+10,628	New	+$3.01M	2.7%	11

Other funds holding KRSA

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MFN Partners's KRSA Position: Q4 2024 in Review

MFN Partners sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2024, closing a stake of 24,209 shares — an estimated $437K sold.

MFN Partners first reported a position in KRSA in Q2 2019 and held it in 22 quarters. The position peaked at $18M in Q3 2019. 18 funds tracked by Wall St. Rank hold KRSA as of Q4 2024.

MFN Partners reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
MFN Partners sold 24,209 Korsana Biosciences, Inc. Common Stock shares in Q4 2024, an estimated $437K.
MFN Partners first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 22 quarters.
MFN Partners's Korsana Biosciences, Inc. Common Stock position peaked at $18M in Q3 2019.
18 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2024.

Based on MFN Partners's 13F filing for Q4 2024, filed 12 Feb 2025.